Switzerland-based biopharma start-up Enzyvant has gained a double fast track status from the FDA for its new rare disease candidate RVT-802. The investigational tissue-based therapy is for the ...
Emerging titanium and rare earths miner Resouro Strategic Metals signs MOU with Minas Gerais state government in Brazil and Invest Minas. The project, within the state of Minas Gerais in Brazil ...